Skip to search formSkip to main contentSkip to account menu

Nanoparticle Albumin-Bound Rapamycin

Known as: Nab-Rapamycin 
The macrolide antibiotic rapamycin bound to nanoparticle albumin with immunosuppressant (see sirolimus) and potential antiangiogenic and… 
National Institutes of Health

Related topics

Related topics

2 relations
ABI-009NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Abstract 2040: Superior therapeutic efficacy of nanoparticle albumin-bound paclitaxel over cremophor-bound paclitaxel in experimental esophageal adenocarcinoma
Introduction: Esophageal adenocarcinoma (EAC) has become the dominant type of esophageal cancer in United States. EAC is the… 
2016
2016
ANALISIS PENGARUH INFLASI, SUKU BUNGA SBI, DAN KURS TERHADAP KINERJA REKSADANA SYARIAH DI INDONESIA (PERIODE WAKTU TAHUN 2010-2014)
Bagi masyarakat Indonesia yang mayoritas adalah muslim, produk-produk investasi perlu dicermati kembali karena dikembangkan dari… 
2016
2016
Nab-paklitakseli haiman adenokarsinooman ensilinjan hoidossa : Arviointikooste
2016
2016
S-1: changing the facets of adjuvant chemotherapy in pancreatic cancer?
From an oncologists view the treatment progress in curatively resected patients for pancreatic cancer (PDAC) has been frustrating… 
2014
2014
ECoNomiC EvaluatioN of NaB-PaClitaxEl Plus GEmCitaBiNE vErsus GEmCitaBiNE aloNE for thE maNaGEmENt of mEtastatiC PaNCrEatiC CaNCEr iN GrEECE
PCN105 ECoNomiC EvaluatioN of NaB-PaClitaxEl Plus GEmCitaBiNE vErsus GEmCitaBiNE aloNE for thE maNaGEmENt of mEtastatiC… 
2013
2013
NAB 2013で見えた新しい技術と放送のうねり (特集 NAB SHOW 2013 注目技術ターゲットレポート)
2012
2012
Abstract OT3-3-05: Neurotoxicity characterization phase II randomized study of nab-paclitaxel versus conventional paclitaxel as first-line therapy of metastatic HER2-negative breast cancer. An…
Background: Nab-paclitaxel (Nab-P) is a nanoparticle albumin-bound form of paclitaxel that is thought to exploit natural albumin… 
2011
2011
P1-14-01: Randomized Phase II Trial of Weekly vs. q 2-Weekly vs. q 3-Weekly Nanoparticle Albumin-Bound Paclitaxel with Bevacizumab as First-Line Therapy for Metastatic Breast Cancer.
Background: Nanoparticle albumin-bound paclitaxel (nab-P) 260 mg/m 2 is superior to paclitaxel 175 mg/m 2 (P) every 3 weeks… 
2008
2008
Toxicology and safety pharmacology of nanoparticle albumin-bound (nab) rapamycin (ABI-009)
5732 Background: The mammalian target of rapamycin (mTOR) is involved in the control of cellular growth and proliferation and is… 
2000
2000
The preparation of a photoreactive analogue of 2′,3′-dideoxyuridine 5′-triphosphate and its use for photoaffinity modification of human replication protein A
A new reagent for photoaffinity modification of biopolymers, 5-[E-N-(2-nitro-5-azidobenzoyl)-3-amino-1-propen-1-yl]-2′,3… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)